Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 May;24(5):1062-5.
doi: 10.1038/leu.2010.20. Epub 2010 Feb 25.

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

Comparative Study

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

J Boultwood et al. Leukemia. 2010 May.
No abstract available

PubMed Disclaimer

Similar articles

Cited by

  • Spliceosomal factor mutations and mis-splicing in MDS.
    Hershberger CE, Daniels NJ, Padgett RA. Hershberger CE, et al. Best Pract Res Clin Haematol. 2020 Sep;33(3):101199. doi: 10.1016/j.beha.2020.101199. Epub 2020 Aug 1. Best Pract Res Clin Haematol. 2020. PMID: 33038983 Free PMC article. Review.
  • Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era.
    Montes-Moreno S, Routbort MJ, Lohman EJ, Barkoh BA, Kanagal-Shamanna R, Bueso-Ramos CE, Singh RR, Medeiros LJ, Luthra R, Patel KP. Montes-Moreno S, et al. PLoS One. 2018 Sep 17;13(9):e0204218. doi: 10.1371/journal.pone.0204218. eCollection 2018. PLoS One. 2018. PMID: 30222780 Free PMC article.
  • Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects.
    Gambacorta V, Gnani D, Vago L, Di Micco R. Gambacorta V, et al. Front Cell Dev Biol. 2019 Oct 11;7:207. doi: 10.3389/fcell.2019.00207. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 31681756 Free PMC article. Review.
  • Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.
    Wang J, Li Z, He Y, Pan F, Chen S, Rhodes S, Nguyen L, Yuan J, Jiang L, Yang X, Weeks O, Liu Z, Zhou J, Ni H, Cai CL, Xu M, Yang FC. Wang J, et al. Blood. 2014 Jan 23;123(4):541-53. doi: 10.1182/blood-2013-05-500272. Epub 2013 Nov 19. Blood. 2014. PMID: 24255920 Free PMC article.
  • Clinical and biological implications of driver mutations in myelodysplastic syndromes.
    Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P, Yoon CJ, Ellis P, Wedge DC, Pellagatti A, Shlien A, Groves MJ, Forbes SA, Raine K, Hinton J, Mudie LJ, McLaren S, Hardy C, Latimer C, Della Porta MG, O'Meara S, Ambaglio I, Galli A, Butler AP, Walldin G, Teague JW, Quek L, Sternberg A, Gambacorti-Passerini C, Cross NC, Green AR, Boultwood J, Vyas P, Hellstrom-Lindberg E, Bowen D, Cazzola M, Stratton MR, Campbell PJ; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium. Papaemmanuil E, et al. Blood. 2013 Nov 21;122(22):3616-27; quiz 3699. doi: 10.1182/blood-2013-08-518886. Epub 2013 Sep 12. Blood. 2013. PMID: 24030381 Free PMC article.

MeSH terms